Notes to the Financial Statements
(Continued)
ৌਕజ
ڝڌ
ൗ
ᚃ
9. Inventories
The Group and HA
ණྠʿᔼ၍҅
At 31 March 2014
HK$’000
2014
ϋ
3
˜
31
˚
ಥ࿆ɷʩ
At 31 March 2013
HK$’000
2013
年
3
月
31
日
港幣千元
Drugs
藥物
1,150,776
1,043,097
Medical consumables
醫療消耗品
188,338
178,996
General consumables
一般消耗品
29,505
29,821
1,368,619
1,251,914
10. Accounts receivable
The Group and HA
ණྠʿᔼ၍҅
At 31 March 2014
HK$’000
2014
ϋ
3
˜
31
˚
ಥ࿆ɷʩ
At 31 March 2013
HK$’000
2013
年
3
月
31
日
港幣千元
Bills receivable [note 10(a)]
應收賬單
[
附註
10(a)]
335,167
297,471
Accrued income
應計收入
16,050
11,991
351,217
309,462
Less: Provision for doubtful debts [note 10(b)]
減：呆賬撥備
[
附註
10(b)]
(57,900)
(49,094)
293,317
260,368
(a)
Aging analysis of bills receivable is set out below:
The Group and HA
ණྠʿᔼ၍҅
At 31 March 2014
HK$’000
2014
ϋ
3
˜
31
˚
ಥ࿆ɷʩ
At 31 March 2013
HK$’000
2013
年
3
月
31
日
港幣千元
Below 30 days
30
日以下
130,647
130,722
Between 31 and 60 days
31
至
60
日
66,432
53,777
Between 61 and 90 days
61
至
90
日
40,375
37,089
Over 90 days
超過
90
日
97,713
75,883
335,167
297,471
9.
π
10.
Ꮠϗሪಛ
(a)
應收賬單的賬齡分析如下：
123
ᔼ৫၍ଣ҅ϋజ
2013-2014
